Presentations & Seminars

Robert S. Roscoe B.Sc.Pharm, ACPR, CDE, CPT

Clinical Collaborative Pharmacist/Certified Diabetes Educator/Medical Education Program Developer/Consultant

Owner R2 Consulting Ltd./

Independent Community Pharmacist/

Team Member Saint John Regional

Diabetes Education Center

NB Diabetes Task Force Member

Expert Committee Member/Co-Author 2013/2018 CDA CPG

4 Beach Drive, Rothesay, N.B.

cell-(506) 654-2555 (with voicemail)        work- (506) 847-5557 (with voicemail)

fax- ( 506) 847-8766                              home-  (506) 847-0711

rob.roscoe@gmail.com

www.robroscoe.ca

 

Presentations & Seminars

 

 

Feb 21,2020 Top Guns 10th Anniversary

Moncton, New Brunswick

 

Diabetes Treatment and Navigating the World of Reimbursement in Making Therapeutic Choices:

“Rob Has Something to Say, Pay Attention – You Can’t Afford Not to Listen

 

Family Physicians, Nurse Practitioners,

Allied Health Practitioners

Merck Canada,

NovoNordisk

Abbott Diabetes Canada

•   Differentiate various criteria for coverage

•              TEACH A PERSON TO FISH rather than GIVE THEM THE FISH

•  Navigate criteria for complex coverage within NB

•              TOOLS TO GO FISHING

•  Appraise NB coverage related to diabetes medication, technologies and supplies

•              THERE COULD BE BETTER SPOTS TO FISH , BUT OURS ISN’T TOO BAD

 

Jan 19,2020 Lilly Lake Pavilion,

Saint John, New Brunswick

 

Why is Diabetes Therapy changing?   

 Cardiovascular Outcome Trials  (CVOT)
Cardiorenal Results
SGLT-2 vs. GLP-1

Pharmacists, Allied Healthcare   Workers Boehringer-Ingelheim ·   Review of CVOT trials and its impact on Diabetes Treatments

·   Review of the CardioRenal Trial results and potential impact on guidelines and Diabetes Treatment

·   Debate which is better SGLT-2 or GLP-1

·   Review benefits and challenges of each of the classes of SGLT-2 & GLP-1  Medications

 

Jan 19,2020 Lilly Lake Pavilion,

Saint John, New Brunswick

 

The LIBRE System: Overview & Reports &

 

Pharmacists, Allied Healthcare   Workers Abbott Diabetes Canada/

Boehringer-Ingelheim

·         Review of the Libre System “Nuts and Bolts”

·         Demonstrate and provide “Hands On” experience with components of the LIBRE system

·         Troubleshoot potential problems in using the system

·         Review of the available Libre Reports and How to Use them

 

Dec 3,2019 Fredericton Medical Centre,

Fredericton, New Brunswick

 

Effective Conversations in Diabetes:

Empowering Patients to Optimize Treatment for Cardiac Protection

 

Family Physicians Boehringer – Ingelheim •   Summarize why cardioprotective benefits are now a major consideration when choosing an anti-hyperglycemic agent for a patient with diabetes and cardiovascular disease

•   Reframe conversations with patients about these medications to focus first and foremost on the cardiovascular risk-reduction benefits

•   Employ strategies to proactively help themselves and their patients conquer barriers (psychological, medical, social and practical) to starting and maintaining these treatments

 

 

Oct 2,2019 Diabetes Canada Winnipeg,

Nova Scotia

 

Updates on the Latest Research and Published Papers

 

Nurse, Nurse Practitioners,

Pharmacists,

Allied HealthCare Workers

BD Diabetes Canada ·         Review and Discuss the latest published papers

·         Open discussions with one of the co-authors

·         Discussions on updates to FIT (Forum for Injection Technique)Canada

 

Sept 4,2019 Little Louis,

Moncton, New Brunswick

 

KEEP IT SIMPLE: Laying a solid foundation for long-term success with long-acting insulins

 

Pharmacist,

Allied HealthCare Practitioners

NovoNordisk •   Recognize when a patient with type 2 diabetes is an appropriate candidate to initiate insulin therapy

•   Apply key takeaways from the 2018 Diabetes Canada Clinical Practice Guidelines (CPGs) to clinical practice to successfully start basal insulin, promote patient self-titration, and conduct effective follow-up

•   Discuss individualization of treatment through analysis of patient and insulin characteristics, with a focus on newer long-acting analogues, as per the 2018 Diabetes Canada CPGs

 

 

May 24,2019 Summerside, Prince Edward Island  

Diagnosis & Treatment of Onychomycosis

 

Family Physicians Bausch Health •    Onychomycosis etiology and diagnosis

•    Urgency to treat

Not just a cosmetic issue

•    Treatment options

Oral therapies

Topical therapies

Canadian clinical pathway

Prevention of recurrence

 

April 25,2019 Delta Fredericton,

Fredericton NB

 

How to Discuss Libre Results: When You do Not have LibreView Reports

 

Large conference,

Nurse, Nurse Practitioners Allied Health Practitioners,

Physicians

Abbott Diabetes Canada ·         Discuss options to review data results with your patients

·         Review the different reports available

·         Discuss the various options on which reports and which order to use

·         Review using the reader/phone to review reports in real time

 

April 13,2019 Hampton Inn

Moncton,NewBrunswick

 

PILLARS: Primary Care Pillars-

Optimizing the Management of Diabetic Kidney Disease

 

Family Physicians, Allied Healthcare,

Pharmacists

Janssen • Define diabetic kidney disease (DKD) and its prevalence

• Recognize unmet needs in the management of DKD

• Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions

Consider the relevance of recent trials and guideline recommendations to your practice

 

March 27,2019 Little Louis,

Moncton, New Brunswick

 

Diagnosis & Treatment of Onychomycosis

 

Nurse, Nurse Practitioners,

Family Physicians

Bausch Health •    Onychomycosis etiology and diagnosis

•    Urgency to treat

Not just a cosmetic issue

•    Treatment options

Oral therapies

Topical therapies

Canadian clinical pathway

Prevention of recurrence

 

March 13-15,2019 Nationally Provided Webex/Webinar  

Insulin Injection Therapy

Optimization Program (I2-TOP)

 

On Line for McKesson

Pharmacists

montmed ·         Review of Impact of Proper Injection techniques[

·         Review components of FIT(Forum for Injection Technique) Canada

·         Identify gaps in proper injection technique and injection site rotation

·         Discussions around Novel products to help meet recommendations for proper injection site rotation including Coloured Needle tips

 

March 12,2019 Thandi’s Saint John

New Brunswick

 

PILLARS: Primary Care Pillars-

Optimizing the Management of Diabetic Kidney Disease

 

Family Physicians, Pharmacists, Allied Healthcare Janssen • Define diabetic kidney disease (DKD) and its prevalence

• Recognize unmet needs in the management of DKD

• Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions

Consider the relevance of recent trials and guideline recommendations to your practice

 

 

Feb 12,2019 Brit’s Saint John

New Brunswick

 

CardioVascular Outcomes Trials (CVOT):

Populations in the Recent Diabetes Outcome Trials:

CARMELINA, CANVAS, DEVOTE, HARMONY, DECLARE, REWIND and CREDENCE

 

 

Family Physicians,

Speciaists

Eli Lilly Canada · Identify similarities and differences amongst the recent CVOT trials

· Relate the populations to the trial outcomes is it a factor or impact

· Discuss the results and outcomes and the populations included

·  Discuss comparisons between the trials and populations studied.

 

Feb 7,2019 George Dumont Hospital

Moncton, New Brunswick

 

PILLARS: Primary Care Pillars-

Optimizing the Management of Diabetic Kidney Disease

 

Nurses, Allied Health care Janssen • Define diabetic kidney disease (DKD) and its prevalence

• Recognize unmet needs in the management of DKD

• Discuss current standards of care in the treatment of DKD and the need for new therapeutic interventions

• Consider the relevance of recent trials and guideline recommendations to your practice

 

Dec 11,2018 Moncton, New Brunswick  

Diagnosis & Treatment of Onychomycosis

 

Family Physicians, Allied Health,Nurses Bausch Health/Valeant •    Onychomycosis etiology and diagnosis

•    Urgency to treat

Not just a cosmetic issue

•    Treatment options

Oral therapies

Topical therapies

Canadian clinical pathway

Prevention of recurrence

 

Nov 15,2018 Coverdale Medical Clinic Riverview,

New Brunswick

 

    The Next Step: Intensifying insulin therapy in patients with type 2 diabetes

 

Type NovoNordisk •    Describe hypoglycemia in basal-insulin-treated patients with type 2 diabetes, assessing its impact on optimizing glycemic control and methods for management

•    Recognize when and how to intensify glycemic control with mealtime insulin

•    Identify glycemic variability and how to effectively manage it

•    Compare new insulins available in Canada

 

 

Nov 6,2018 Petitcodiac Medical Centre

Petitcodiac, New Brunswick

 

In Control: Long-acting insulins for the management of type 2 diabetes

 

 

Family Physicians NovoNordisk •  Establish the role of basal insulin therapy in the management of type 2 diabetes mellitus (T2DM) as per the 2018 Diabetes Canada clinical practice guidelines

•  Apply strategies to overcome common challenges associated with insulin initiation and optimization and employ knowledge of key concepts, including glucose variability, hypoglycemia and continuous glucose monitoring

•  Compare agent-specific characteristics of the available basal insulins, with a focus on newer basal insulins

 

Nov 3,2018 Montreal Quebec  

FIT (Forum for Injection Technique) Videos

 

Video Tape Program BD Canada/ Health Choices First •    Taking The Injection Techniques and putting it in a demonstration video

•    Utilizing white board techniques to clarify those principles.

 

Oct 29,2018 Rodd Inn Miramichi

Miramichi ,New Brunswick

 

KEY:  Keep Educating Yourself

Evidence and Diabetes Guidelines for Primary Care Physicians

 

Family Physicians, Pharmacists Janssen •   Practical review of the 2018 Diabetes Canada Clinical Practice Guidelines

•   Review the results of recent clinical studies with SGLT2 inhibitors

•   Use case-based scenarios to help apply and synthesize learnings

 

Oct 28,2018 Fredericton, New Brunswick  

Casting New Light on Basal Insulins:

Overcoming Challenges in Diabetes Management with Next Generation Basal Insulins

Family Physicians,  Pharmacists,  Allied Health Professionals Sanofi Canada •   Describe how new basal insulin therapies allow patients to achieve safer glycemic goals

•   Discuss recent clinical trial results surrounding the action profiles of longer-acting basal insulins

•   Recognize the differences between the available longer-acting basal insulin therapies as demonstrated by recent head-to-head clinical trial results and real-world evidence

 

 

 

Oct 23,2018 Moncton Medical Centre Moncton, New Brunswick  

KEY:  Keep Educating Yourself

Evidence and Diabetes Guidelines for Primary Care Physicians

 

Nurses, Allied Health Professions Janssen •   Practical review of the 2018 Diabetes Canada Clinical Practice Guidelines

•   Review the results of recent clinical studies with SGLT2 inhibitors

•   Use case-based scenarios to help apply and synthesize learnings

 

Oct 15,2018 Diabetes Canada Symposium

Halifax, Nova Scotia

 

The Winning Edge

 

Type BD Canada •  Review FIT 3rd Version Recommendations/Proper Injection Techniques Principles

•  Review FIT Technique Plus tools for daily practice

•  Also provided Q & A session around injection technique

 

July 17,2018 Montreal Quebec  

3 Minute Intervention for Injection Technique

 

Video Tape

Lesson

montmed •   Review Proper Injection Technique Principles

•   Develop and Provide “Real Life 3-Minute Intervention” demonstration

•   Also provide Q & A session around injection technique.

 

May 17,2018 Oromocto Medical Centre  

Translating the New Evidence in the Management of Type 2 Diabetes

 

Family Physicians AstraZeneca •   Review the impact of underlying cardiovascular disease on antihyperglycemic selection

•   Examine new evidence impacting antihyperglycemic selection since the November 2016 Interim Update to the Diabetes Canada Clinical Practice Guidelines

•   Review the selection of antihyperglycemic medication for a patient without CVD who is not reaching glycemic targets with metformin monotherapy

•   Discuss the significance of CVD primary prevention results with antihyperglycemics

 

 

May 15,2018 Brookside Medical Clinic Fredericton New Brunswick Choosing DPP4i, SGLT2i, or Both,as Add-ons to Metformin:
Patient Baseline Characteristics are Crucial
Family Physicians Merck Canada SUMMARY:

Introduction

•     Glycemic management in Canada

•     CDA Guidelines

DPP-4i or SGLT2i?

•     Use of baseline A1C

•     Monotherapy

•     Dual Therapy (Add-on to Metformin)

•     Triple therapy (Add-on to Metformin + SU)

•     Use of baseline eGFR

•     Use in the elderly

Triple therapy

•     SGLT2i add-on to metformin + DPP-4i

•     DPP-4i add-on to metformin + SGLT2i

•     DPP-4i + SGLT2i dual add-on therapy to metformin

MetaboliceffectsofDPP-4iandSGLT2i:
Focus on glucagon and endogenous glucose production

 

 

May 5,2018 Prince Edward Island Pharmacist Annual Meeting

Charlottetown, P.E.I

 

Basal Insulins:
What’s New, What’s Changed, What’s Stayed the Same

(What the Pharmacist Needs to Know)

 

Pharmacists, Allied Health Professionals Sanofi •    Understand the current challenges with basal insulin

•    Review 2 new glargine basal insulin options:

•     Insulin glargine 300 U/mL (Toujeo™)

•    Subsequent entry biologic (SEB) of insulin glargine 100 U/mL       (Basaglar™)

•    Review insulin degludec TRESIBA

•    Review the Toujeo™SoloStar® injection device to ensure safety

•    Discuss how to initiate, transfer and monitor patients on ToujeoTM

 

 

 

 

May 4,2018 Day in Family Health Halifax, Nova Scotia  

Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes

 

Family Physicians Janssen · Evaluate the cardiorenal complications of diabetes

· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials

· Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice

Differentiate results from large randomized trials and real-world studies

 

May 2,2018 Moncton, New Brunswick  

BASAL INSULIN: The truth about newer basal insulin options

 

Allied Health NovoNordisk • Describe challenges, such as hypoglycemia, associated with basal insulin initiation and optimization

• Evaluate the pharmacokinetics, safety and efficacy of new basal insulins, and identify differentiating benefits

• Discuss mechanisms to simplify basal insulin initiation and optimization

 

 

April 26,2018 Bathurst, New Brunswick  

Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes

 

Family Physicians ,Allied Healthcare Janssen · Evaluate the cardiorenal complications of diabetes

· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials

· Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice

· Differentiate results from large randomized trials and real-world studies

 

March 28,2018 Rexton Medical Centre

Rexton, New Brunswick

 

Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes

 

Family Physicians Janssen · Evaluate the cardiorenal complications of diabetes

· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials

· Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice

· Differentiate results from large randomized trials and real world studies

 

March 26,2018 Moncton City Hospital Moncton, New Brunswick  

Be The Expert: SGLT-2 Inhibition and Cardiorenal Outcomes

 

Family Physicians, Nurses, Physicians Janssen · Evaluate the cardiorenal complications of diabetes

· Discuss the mechanism of action of SGLT2 inhibitors and their efficacy and safety data from Phase 3 trials

· Explain the cardiorenal results from outcome trials with SGLT2 inhibitors and integrate into clinical practice

· Differentiate results from large randomized trials and real world studies

 

Feb 13,2018 Brookside Medical Centre Fredericton NB The HCP’s Guide to the Galaxy of

CVOTs and GLP-1RAs

Family Physicians, Nurses NovoNordisk •          •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•

•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class•

•Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines

 

 

Dec 7, 2017 Base Gagetown, New Brunswick The HCP’s Guide to the Galaxy of

CVOTs and GLP-1RAs

Family Physicians, Nurse Practitioners,

Allied Health Practitioners

NovoNordisk •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•

•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class•

•Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines

 

 

 

 

Nov 30,2017 Oromocto, New Brunswick The HCP’s Guide to the Galaxy of

CVOTs and GLP-1RAs

Family Physicians, Nurse Practitioners,

Allied Health Practitioners

NovoNordisk •Summarize the results of contemporary CV outcome trials in type 2 diabetes, with a focus on practice-changing outcomes•

•Reflect on specific patient and agent characteristics and how to optimize T2D management using the evolving GLP-1RA class•

•Discuss how to integrate GLP-1RAs into practice, based on the Diabetes Canada guidelines

 

 

 

 

 

 

 

 

Nov 7,2017 Moncton, New Brunswick The Pharmacist’s Role in Interconnected Diabetes Care

Engaging Patients and Growing Your Pharmacy Business

 

Pharmacists, Nurse Practitioners , Allied Healthcare Ascensia Diabetes ·         Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for 
your patients

·         Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence

Utilize a case study to help build a management plan for your diabetes patients            including nutrition, activity, monitoring, 
and follow-ups

Identify key areas to leverage the Expanded Scope of Practice 
(includes case discussion of Business Model canvas)

 

 

Oct 25,2017 Mirimachi, New Brunswick The Pharmacist’s Role in Interconnected Diabetes Care

Engaging Patients and Growing Your Pharmacy Business

 

Pharmacists, Nurse Practitioners , Allied Healthcare Ascensia Diabetes ·         Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for 
your patients

·         Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence

Utilize a case study to help build a management plan for your diabetes patients            including nutrition, activity, monitoring, 
and follow-ups

Identify key areas to leverage the Expanded Scope of Practice 
(includes case discussion of Business Model canvas)

 

 

Oct 17,2107 Fredericton, New Brunswick  

“Real World Evidence im Basal Insulin Therapy”

 

Family Physicians, Nurse Practitioners,

Pharmacists

 

Sanofi •To assess the clinical characteristics and outcomes of patients with T2D who transferred to Gla-300 from other basal insulin analogs in the US.

•To evaluate real-word hypoglycemia risk and clinical outcomes in patients with T2D who had been receiving treatment with basal insulin and transferred to Gla-300

•To compare changes in clinical measures before and after initiation and dosage of Gla-100 and Gla-300 in insulin-naïve patients with T2D in a real-world setting

•To evaluate clinical outcomes of patients with T2D using basal insulin who were transferred to either Gla-300 or other basal insulins in real-world clinical practice

 

 

Sept 20,2017 Fredericton, New Brunswick The Pharmacist’s Role in Interconnected Diabetes Care

Engaging Patients and Growing Your Pharmacy Business

 

Pharmacists, Nurse Practitioners , Allied Healthcare Ascensia Diabetes ·         Identify recent improvements in glucose monitoring technology and connected devices and determine the most appropriate glucose monitoring device for 
your patients

·         Learn how to optimize and seamlessly implement diabetes digital health monitoring into your pharmacy workflow to drive patient adherence

Utilize a case study to help build a management plan for your diabetes patients            including nutrition, activity, monitoring, 
and follow-ups

Identify key areas to leverage the Expanded Scope of Practice 
(includes case discussion of Business Model canvas)

 

 

 

 

June 27,2017 Shediac New Brunswick  

1,2,3 Go!

 

Family Physicians, Nurse Practitioners Janssen •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)

•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease

•Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events  in patients with T2DM (hypoglycemia, SADMANS…)

 

June 21,2017 Elmsdale Clinic New Brunswick  

1,23, Go!

 

PrimaryCare Physicians Janssen •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)

•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease

•Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events  in patients with T2DM (hypoglycemia, SADMANS…)

 

June 20,2017 LIVE WEBNAR Provider  

Evolution of mealtime control: Advancements towards a physiologic profile

 

On Line Presentation Allied Healthcare Providers NovoNordisk •Identify approaches to address challenges in mealtime insulin management.

•Describe the pathophysiology of postprandial hyperglycemia in diabetes.

•Explore the rationale and applicability of rapid-acting insulin analogues in type 1 and type 2 diabetes

 

 

June 14,2017 Moncton Hospital, New Brunswick 1,2,3 Go!

 

Atlantic Meeting of Shoppers Drug Mart Jannsen •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)

•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease

•Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events  in patients with T2DM (hypoglycemia, SADMANS…)

 

April 26,2017 Oromocto, New Brunswick 1,2,2  Go !

 

Primary Care Physicians, Nurse Practritrioners Janssen •Review the rationale for optimizing glucose control early in treatment and the importance of treating to targets (HbA1c, BP and lipids)

•Understand the Vascular Protection Check list and how to manage patients with and without established cardiovascular disease

•Discuss “matching the agent to the patient” based on the November 2016 CDA-CPG Update with a focus on exploring strategies that avoid or minimize the risk of adverse events  in patients with T2DM (hypoglycemia, SADMANS…)

 

 

 

Feb 4,2017 Moncton,New Brunswick “Navigating the Complex World of Coverage and Patient Access”

 

Primary Care Physicians, Nurse Practitioners Top Guns Planning Committee ·         Review of CDA CPG 2016 update A1c treatment goals

·         Review of the CDA CPG 2016 pharmacological management 2016 update

·         Discuss the various coverage options for patients from different backgrounds and insurance coverages

·         Discuss the various treatment barriers and potential approaches to facilitate quick and efficient methods in obtaining approvals

 

 Dec 8,2016 Riverside-Albert Medical Clinic  

CVOT’s: Getting to the Heart of the Matter

 

Primary Care Physicians, Nurse practitioners, general nursing NovoNordisk General review of cardiovascular risk in patients with diabetes and reviewing briefly older trials, then leading to the latest CVOT LEADER, SUSTAIN, Empa-REG, and review the results then discussion using case studies on where these agents may be best utilized based on the evidence.

 

Nov 2,2016 Saint John Regional Hospital, Saint John New Brunswick  

Subsequent Entry Biologics (SEB): A New option in Insulin Therapy

 

Diabetes Education Centre, Nurse CDE, Medical students Eli Lilly Canada ·         Differentiate SEBs from a manufacturing and a regulatory perspective;

·         Explain the differences between subsequent entry biologic (SEB)
and reference products;

·         Describe the safety and efficacy of SEB insulin

·         Identify the clinical implications surrounding the arrival of SEB insulin

 

 

Oct 22/23,2016 Toronto, Ontario  

Diabetes Gadgets & Gizmos: Helping patients select, start, and succeed with diabetes devices

 

Pharmacists & Pharmacists CDE ‘s API (Allied Pharmacists Inc.)

 

Multiple presentation provided utilizing Ppt. and interactive sessions with the following learning objectives:

 

•       Recognize the role that diabetes devices play in enhancing patient self-management

•       Compare and contrast available diabetes devices and explain key features and benefits

•       Select the most suitable devices to individualize diabetes care based on patient characteristics and management goals

 

OCT 20,2016 Moncton New Brunswick  

The Pharmacist’s Role in the
Management of Type 2 Diabetes — Integrating SGLT2 Inhibitors

Pharmacy Owners, Pharmacists, Pharmacist CDE’s Janssen, Johnson & Johnson
  • Description Describe publically funded pharmacy services available for patients with diabetes
  • Understand when and why pharmacists should intervene for patients with diabetes
  • Explain the pathogenesis of diabetes and where current medications fit in the treatment of patients with T2DM
  • Review the role of SGLT2 inhibitors in the treatment of T2DM, including efficacy, side effects and safety
  • Discuss how individualization of therapy can be used to choose when a SGLT2 can be recommended for a patient with T2DM

 

 

October 6,2016 Tracadie, New Brunswick EVOLUTION OF TYPE 2 DIABETES MANAGEMENT

 

Nurse Practitioners Annual General Meeting Merck Canada ·         Differentiate between non-insulin options for patients not at A1C target

·         Appraise and interpret data emerging from large T2DM CV safety trials

·         Personalize glucose-lowering therapy according to patient characteristics and CV risk profile

 

September 27,2016 Fredericton, New Brunswick  

Basal Insulins:
What’s New, What’s Changed, What’s Stayed the Same :
(What the Pharmacist Needs to Know)

 

Pharmacist CDE’s Sanofi Canada •       Understand the current challenges with basal insulin

•       Review 2 new glargine basal insulin options:

–      Insulin glargine 300 U/mL (Toujeo™)

–      Subsequent entry biologic (SEB) of insulin glargine 100 U/mL       (Basaglar™)

•       Review the Toujeo™ SoloStar® injection device to ensure safety

•       Discuss how to initiate, transfer and monitor patients on ToujeoTM

 

 

 

 

Sept 21,2016 Minto, New Brunswick Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Nurse Practitioner Regional Diabetes Training Astra Zeneca ·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

June 22,2016 Halifax, Nova Scotia  

Injectable Therapies: Oh the challenges!! ,

Too Many Choices –How do we choose?

Just whose job is it anyway?

 

Professional Sales Staff Astra Zeneca ·         Update and discussions surrounding Injectable therapies for Diabetes

·         Identify the differences between the products and discuss how they may be positioned.

·         Discussion on the new agents available: coverage, how do we choose, where does it fit

·         Discussion on the who has the best role in educating the patient on their options.

·         Discussion on who is best suited to do the injectable training.

 

 

June 10,2016 Moncton, New Brunswick Managing Your Patients with Onychomycosis: “I am Embarrassed to Take my Shoes Off”

 

Canadian Federation of Podiatry Medicine National Convention. Valeant Pharmaceuticals ·         Assess a patient presenting with common signs and symptoms of onychomycosis

·         Review a patient for factors that increase the risk of onychomycosis infection

·         Counsel a patient on the goals of treatment and expectations of pharmacotherapy

·         Determine the role for systemic or topical therapy in the management of onychomycosis

·         Educate a patient on strategies to reduce their risk of onychomycosis or a recurrence of the infection

 

 

May 26,2016 WEBNAR Diabetes Management : From Head to Toe

 

Open attendance to the province. CDE, Dietitians, Nurse, Pharmacists, etc Valeant Pharmaceuticals This Live WEBNAR offered 3 main topics:

·         The role of compliance and improving outcomes: are the Extended Release products a better choice in some patients?

·         The evolving role of Lodalis (Colesevelam) in managing the diabetes patient who also is not at goal with their lipid targets

·         The Increased incidence of Onychomycosis in Diabetes, the increased risk of complications due to Onychomycosis, and what are the treatment options available , and how to use them.

 

 

May 6,2016 Fredericton ,New Brunswick  

Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Community Health Centre Professional Staff Education Meeting, Nurse, Nurse Practitioner, Physicians.

Practical Nurses

Astra Zeneca ·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

 

 

March 29,2016 Hillside Medical Centre

Fredericton, New Brunswick

 

New CDA Clinical Practice Guideline Interim Update and Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Primary Care physicians, Medical students, staff nurses Astra Zeneca ·         Update Program and inform participants of the Treatment Algorithm update that occurred 24 hours earlier

·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

March 10,2016 Saint John, New Brunswick  

Pharmacy Practice Pilot Presentation

 

Pharmacists & Pharmacist CDE’s +

Pharmacy Students

Sanofi •       Understand the current challenges with basal insulin

•       Review 2 new glargine basal insulin options:

•       Insulin glargine 300 U/mL (Toujeo™) and

Biosimilar of insulin glargine 100 U/mL (Basaglar™)

•       Review the injection device to ensure safety

•       Discuss how to initiate, transfer and monitor patients on ToujeoTM

 

Feb 19,2016 LIVE WEBNAR  

“I am Embarrassed to Take my Shoes Off” : Managing your Patients with Onychomycosis

 

Open attendance to the province. CDE, Dietitians, Nurse, Pharmacists, etc. Valeant ·           Assess a patient presenting with common signs and symptoms of onychomycosis

·           Review a patient for factors that increase the risk of onychomycosis infection

·           Counsel a patient on the goals of treatment and expectations of pharmacotherapy

·           Determine the role for systemic or topical therapy in the management of onychomycosis

·           Educate a patient on strategies to reduce their risk of onychomycosis or a recurrence of the infection

 

Feb 11,2016 Auberge le Vieux Presbytere de Bouctouche

 

 

Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Primary Care Physicians Area Group Mtg. Astra Zeneca ·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

 

 

Jan 26,2016 Moncton/Dieppe Podiatric Diabetes & care Centre  

INSIDE INSULIN PUMPS: A comparison of rapid-acting insulin analogues

Teaching Staff at the Diabetes Centre. Physicians, Nurse Practitioners, Nurse CDE’s NovoNordisk Topics were arranged by request and included:

 

•          STABILITY OF RAIA IN CSII:IN VITRO STUDIES

•          Clinical trials comparing RAIA in CSII

•          CSII is based on a continuous infusion of insulin via an external pump, addressing both basal and prandial requirements1

•          CSII allows administration of insulin that closely mimics physiological secretion of insulin2

•          Properties of a ideal rapid-acting insulin analogue for optimal use in CSII include3:

•       Rapid-action

•       Soluble

•       Uniform absorption characteristic

 

 

Feb 19,2106 Fredericton, New Brunswick  

New Advances in Insulin Therapy

 

Pharmacists with interest in Diabetes & Pharmacist CDE Sanofi •       Provide guidance and support to family members and patients living with type 2 diabetes (T2D);

•       Describe the current challenges with insulin use and desired properties of new insulins;

•       Define what a biosimilar is and introduce the clinical profile of biosimilar glargine (LY2963016);

•       Review key clinical outcomes from long-acting basal insulins recently approved and in development;

•       Explain the rationale and benefits of the fixed combination of basal insulin and GLP-1 receptor agonist therapy in the management of T2D; and

•       Describe key clinical trial outcomes from two upcoming bolus insulin therapies.

 

 

Dec 18,2015 Saint John Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Nurse Practitioners Astra Zeneca ·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

November 25,2015 Moncton, New Brunswick  

Finding the Key to Individualizing Treatment in Type 2 Diabetes

 

Aboriginal Diabetes Initiative Atlantic Meetings Astra Zeneca ·         Identify appropriate therapeutic targets for individuals with Type 2 Diabetes, particularly those with comorbidities or complications

·         Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors

·         Distinguish the role of newer pharmacological agents as add-on therapies to metformin

 

 

Aug 10,2015 Oulton College Moncton, New Brunswick  

Diabetes Gadgets & Gizmos: Helping patients select, start, and succeed with diabetes devices

Pharmacy Technician Class NovoNordisk Multiple presentation provided utilizing Ppt. and interactive sessions with the following learning objectives:

 

•       Recognize the role that diabetes devices play in enhancing patient self-management

•       Compare and contrast available diabetes devices and explain key features and benefits

•       Select the most suitable devices to individualize diabetes care based on patient characteristics and management goals

 

 

June 11,2105 Saint John, New Brunswick  

How to Initiate the Insulin Conversation With Your Patients

Dispensing Pharmacists, Pharmacist CDE’s Bayer HealthCare
  • Discuss the most common types of insulin regimens and their mode of action
  • Explain the complications associated with hypoglycemia and the risk of cardiovascular (CV) events
  • Implement an action plan for insulin patients by utilizing  expanded scope of practice

 

 

 

May 29,2016 Ottawa, Ontario  

O.P.T.I.O.N.S
Offering Pharmacists Therapeutic Interventions & Optimizing Next Steps

Canadian Pharmacists Annual Convention Canadian Pharmacists Association/Pfizer Overview of the style clinics that I am providing to Primary Care Offices:

·         Discussion on how they started, how they are evolving, possible future steps.

·         Presented a typical process of a clinic

·         Answered Questions as par of a panel once project was presented

 

 

May 23, 2016 Fredericton New Brunswick  

The Role of the Kidneys in Diabetes Control: Focus on SGLT2 Inhibitors-Concept and Questions

 

 

New Brunswick Pharmacists Annual Convention Janssen •       Describe  the mechanism for the reabsorption of glucose in the kidneys;

•       Describe the SGLT2 inhibitors  (sodium/glucose cotransporter 2), their mode of action and pharmacodynamic effects;

•       Discuss the potential role of SGLT2 inhibitors in the treatment of type 2 diabetes.

 

 

 

 

 

 

 

 

May 23,2015 Fredericton New Brunswick  

Medtronic Diabetes Updates

 

New Brunswick Diabetes Educators Annual Meeting Medtronic/Bayer HealthCare Variety of a series of general updates on:

·         Insulin Pumps

·         New Blood Glucose Meters

·         New Therapies available

·         General discussions within the group of 50 + participants

 

 

 

 

April 10,2016 Live WEBINAR  

Glumetza – where does it fit in diabetes management?

Lodalis – where does it fit in the diabetic hypercholesterolemia comorbidity patient?

 

Open to all Diabetes Educators and Diabetes Centres in New Brunswick Valeant Pharmaceuticals ·         The role of compliance and improving outcomes : are the Extended Release products a better choice in some patients.

  • Description Why LDL-C Matters
  • Reaching Therapeutic Goals: Challenges
  • Statin Therapy in a Nutshell
  • Open Forum on Add-on Therapy options
  • Lodalis Mode of Action
  • Lodalis Efficacy Data
  • Lodalis Primary Features
  • Lodalis vs. other Add-On Therapies
  • Lodalis reimbursement across Canada
  • Open Forum on Lodalis Clinical Use

 

 

 

Feb 27,2016 Halifax, Nova Scotia  

“Hands On” Diabetes

Primary Care Physicians B/D Canada •          Troubleshoot the practical aspects of insulin injection with suboptimal glycemic control on insulin (injection technique, site complications)

•          Assess for and manage lipohypertrophy

•          Perform a proper foot exam, including the use of a monofilament to detect neuropathy

 

 

 

Feb 28,2015 Live Webinar/Webex  

“ Unique Therapeutic Agents for Diabetes and Your “Cholestabetes” Patient”

 CDE Nurse, Dietitians, Pharmacists Valeant Pharmaceuticals ·         Discussing the role of Colesevelam in the management of Hypercholesteremia when statins are not enough especially in the Diabetes population.

·         Discussion of novel therapeutic approaches to management of Diabetes especially when Metformin is resulting in tolerance issues. Role of Extended Release Metformin

·         How these therapeutic agents work, where might they fit in the continuum of treatment, where should they not be used, proper dosing and usage information

 

 

Feb 28,2015 Dartmouth Nova Scotia  

“ Hands on Diabetes”

Primary Care physicians as part of Accredited disease Updates BD Healthcare ·         Troubleshoot the practical aspects of insulin injection with sub-optimal glycemic control. Emphasis on insulin/injection technique & site complications.

·         Assess for and manage Lipohypertrophy

·         Perform a proper foot exam, including the use of a monofilament to detect and screen for neuropathy.

 

 

 

Feb 9,2015 Toronto Ontario  

FIT Forum for Injection Technique Canada: Recommendation for Best Practice In Inj- 2nd EDITION Updates and What’s new /Changed.

 CDE Pharmacists BD Healthcare As indicated by the title review of the FIT Injection Recommendations as a review of what was updated from the previous edition, challenges presented with the first edition and new information that resulted from these questions, New sections on GLP-1’s (Incretin therapies) , and updates on existing sections provided. A review of the recommendations as well provided identifying where the document has been updated, and what has changed.

 

 

 

 

Nov 6,2014 Hamilton Ontario  

Motivational Interviewing: Getting to the point

 

 Ontario Nurse Practitioner Annual AGM & Conference Antibody Commnications

NovoNordisk Canada

The program will help enable the attendees to:

  • Identify the role for both insulin and non-insulin injectable therapies in diabetes management according to Canadian Diabetes Association (CDA) 2013 Clinical Practice Guidelines

·         Recognize challenges faced by healthcare providers (HCPs) in the recommendation and initiation of injectable therapies in diabetes management

  • Utilize motivational interviewing techniques to identify and overcome common patient challenges related to insulin and non-insulin injectable therapies

 

 

 

Nov 1,2014 Halifax, Nova Scotia  

Evolution of a Retail Pharmacy Practice

 

College of Pharmacy Address R-2 Consulting Ltd ·         Delivered the evolution of how my practice stepped up from dispensing to now practicing within a variety of physicians offices.

·         How I started , what went wrong- what really worked, role of mentorships, what next steps I see for the graduates, discussions around their point of view .

 

 

 

 

Oct 8,2014 Saint John, New Brunswick Southern New Brunswick Pharmacist CDE Group Meeting

 

Pharmacist CDE CME Sanofi ·         Presented the approach of the Basal + approach of additional insulin therapy comparing it to other insulin advancement therapies.

·         Facilitated the delivery of discussions around the expanded role of pharmacists, tools that work, experience around the communication with other healthcare professionals, taking it to the next level.

 

 

Oct 2-3,2014 Gander, Newfoundland Talk of the Town SGLT-2’s

 

CDE Certified Diabetes Educators Central /Provincial Conference Janssen ·         Describe the glucose reabsorption mechanism in the kidney;

·         Explain the SGLT2 inhibitors, their pharmacodynamics effects and their role in Type 2 diabetes;

·         Discuss the indications and appropriate clinical applications of canagliflozin, the first in the SGLT2 inhibitor class for Type 2 diabetes management.

 

 

 

June 9-11,2014 Saint John’s, Newfoundland

 

 

Feel IT, Try IT, Switch IT”

Exploring Lipohypertrophy

& Benefits of proper Injection Technique

UPDATED VERSION

 

Pharmacist CME

 

BayerHealthcare/ BD Healthcare Description: Upon completion of this continuing professional development program, participants will be better able to:

 

Feel IT

 

•       Understand what lipohypertrophy is, how it develops and how to prevent it.

•       Learn how you can assess and identify lipohypertrophy (lipos) in your practice.

•       Review practical tips for treatment of lipohypertrophy.

 

Try IT

 

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

 

Switch IT

 

•       Understand the impact of needle length in relation to lipohypertrophy.

 

 

 

 

May 23,2014 Moncton, New Brunswick Beyond Metformin, Navigating The Treatment Continuum For Your Patients With Type 2 Diabetes
Pharmacist CDE NovoNordisk Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Recognize the rationale for timely initiation and intensification of treatment to achieve glycemic targets

•       Understand how currently available treatment options compare with respect to key challenges in diabetes management: A1C, weight and hypoglycemia

•       Implement effective strategies to help patients and health practitioners overcome barriers to treatment at various stages of the treatment continuum

•       Recognize importance of establishing individualized targets (i.e., A1C, weight) based on patient characteristics

 

 

 

 

May 14,2014 Saint John, New Brunswick

 

 

Feel IT, Try IT, Switch IT”

Exploring Lipohypertrophy

& Benefits of proper Injection Technique

UPDATED VERSION

 

Pharmacist CME

 

Bayer Healthcare/ BD Healthcare Description: Upon completion of this continuing professional development program, participants will be better able to:

 

Feel IT

 

•       Understand what lipohypertrophy is, how it develops and how to prevent it.

•       Learn how you can assess and identify lipohypertrophy (lipos) in your practice.

•       Review practical tips for treatment of lipohypertrophy.

 

Try IT

 

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

 

Switch IT

 

•       Understand the impact of needle length in relation to lipohypertrophy.

 

 

May 1, 2014 Vancouver, British Columbia It’s a Good Time to talk About Insulin.

“ So Why is This Not Happening”

 

Pharmacist CME

 

Sponsor: BD Healthcare, WalMart Canada Corporate Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Understand the concept of clinician inertia regarding starting insulin for Type 2 Diabetes.

•       Understanding the benefits of early insulinization for Type 2 Diabetes and become familiar with strategies to overcome barriers to initiating discussions of insulin with those with Type 2 Diabetes.

•       Understand the concept of psychological insulin resistance (PIR) in patients with Type 2 diabetes and become familiar with how to assess PIR in those living with Type 2 Diabetes.

·         Become familiar with change interventions using motivational interviewing, cognitive restructuring and fear management

 

 

April 25,2014 Fredericton, New Brunswick  

Feel It, etc,

 

Physician/

Nurse Practitioner/

Dietitian

Pharmacist CME

(Multidisciplinary Healthcare Provider Presentation

B/D Healthcare Description: Upon completion of this continuing professional development program, participants will be better able to:

 

Feel IT

 

•       Understand what lipohypertrophy is, how it develops and how to prevent it.

•       Learn how you can assess and identify lipohypertrophy (lipos) in your practice.

•       Review practical tips for treatment of lipohypertrophy.

 

Try IT

 

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

 

Switch IT

 

•       Understand the impact of needle length in relation to lipohypertrophy.

 

 

April 25,2014 Fredericton, New Brunswick  

SGLT-2  The New Kid on the Block

 

Physician/

Nurse Practitioner/

Dietitian

Pharmacist CME

(Multidisciplinary Healthcare Provider Presentation

Jannsen ·         Describe the glucose reabsorption mechanism in the kidney;

·         Explain the SGLT2 inhibitors, their pharmacodynamic effects and their role in Type 2 diabetes;

·         Discuss the indications and appropriate clinical applications of canagliflozin, the first in the SGLT2 inhibitor class for Type 2 diabetes management.

 

 

April 24,2014 Fredericton, New Brunswick  

Insulin Academy

 

Physician/

Nurse Practitioner/

Dietitian

Pharmacist CME

(Multidisciplinary Healthcare Provider Presentation

NovoNordisk By the end of this program, participants will be able to:

•       Identify when T2DM patients need to start insulin therapy

•       Implement simple strategies for starting insulin

•       Identify T2DM patients currently on basal insulin therapy that need mealtime insulin

•       Implement simple strategies to add and adjust mealtime insulin

 

 

 

 

 

April 4, 2014 Toronto, Ontario It’s a Good Time to talk About Insulin.

“ So Why is This Not Happening”

 

Pharmacist CME

 

Sponsor: BD Healthcare, WalMart Canada Corporate Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Understand the concept of clinician inertia regarding starting insulin for Type 2 Diabetes.

•       Understanding the benefits of early insulinization for Type 2 Diabetes and become familiar with strategies to overcome barriers to initiating discussions of insulin with those with Type 2 Diabetes.

•       Understand the concept of psychological insulin resistance (PIR) in patients with Type 2 diabetes and become familiar with how to assess PIR in those living with Type 2 Diabetes.

·         Become familiar with change interventions using motivational interviewing, cognitive restructuring and fear management

 

 

 

April 2,2014 Moncton, New Brunswick “Feel IT, Try IT, Switch IT”

Exploring Lipohypertrophy

& Benefits of proper Injection Technique

UPDATED VERSION

 

Pharmacist CME

 

Sponsor: BD HealthCare, Lilly Canada,

Bayer Healthcare

Description: Upon completion of this continuing professional development program, participants will be better able to:

 

Feel IT

 

•       Understand what lipohypertrophy is, how it develops and how to prevent it.

•       Learn how you can assess and identify lipohypertrophy (lipos) in your practice.

•       Review practical tips for treatment of lipohypertrophy.

 

Try IT

 

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

 

Switch IT

 

•       Understand the impact of needle length in relation to lipohypertrophy.

 

 

 

Feb 25,2014 Sussex, New Brunswick Beyond Metformin, Navigating The Treatment Continuum For Your Patients With Type 2 Diabetes
Physician, Family Practice CME

 

Sponsor: NovoNordisk Canada Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Recognize the rationale for timely initiation and intensification of treatment to achieve glycemic targets

•       Understand how currently available treatment options compare with respect to key challenges in diabetes management: A1C, weight and hypoglycemia

•       Implement effective strategies to help patients and health practitioners overcome barriers to treatment at various stages of the treatment continuum

•       Recognize importance of establishing individualized targets (i.e., A1C, weight) based on patient characteristics

 

 

 

January 30,2014 Toronto, Ontario “Feel IT, Try IT, Switch IT”

Exploring Lipohypertrophy

& Benefits of proper Injection Technique

UPDATED VERSION

 

Pharmacist CME

 

Sponsor: BD HealthCare, Metropolitan Toronto Pharmacists Association

(MTPA)

Description: Upon completion of this continuing professional development program, participants will be better able to:

 

Feel IT

 

•       Understand what lipohypertrophy is, how it develops and how to prevent it.

•       Learn how you can assess and identify lipohypertrophy (lipos) in your practice.

•       Review practical tips for treatment of lipohypertrophy.

 

Try IT

 

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

 

Switch IT

 

•       Understand the impact of needle length in relation to lipohypertrophy.

 

 

 

Nov 3, 2013 Halifax, Nova Scotia INCRETIN THERAPIES: THEY’RE HERE,NOW WHAT?

Answering your most frequently asked questions

 

Pharmacist CME

 

Sponsor: PANS                 (Pharmacy Association of Nova Scotia) Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Understand the two classes of incretin agents and their mode of action

•        Differentiate between GLP-1 receptor agonists and DPP-4 inhibitors

•       Review the efficacy and safety data of currently available incretin agents and where they fit in the 2013 CDA guidelines

•       Explain how to optimally incorporate incretin therapies into clinical practice and to discuss the rationale for a personalized evidence-based approach to care

 

 

 

 

Oct 18, 2013 Montreal, Quebec Diabetes Painful NEUROPATHY: A Pharmacy Case

 

National Diabetes/ Vascular Convention

(Vascular 2013)

Sponsor: Canadian Diabetes Association (CDA) As lead author provided a case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion

 

Description: Upon completion of this continuing professional development program, participants will be better able to:

•       List the signs, symptoms, and risk factors for developing DPN

•       Screen for DPN as part of routine management of diabetes and its co-morbidities

•       Apply tools to counsel the patient on evidence-based treatment options for painful DPN, and follow up with appropriate interventions

•       Discuss the basic concepts of good foot care to prevent and screen for diabetes foot complications

 

 

 

Oct 10, 2013 Rothesay, New Brunswick INCRETIN THERAPIES: THEY’RE HERE,NOW WHAT?

Answering your most frequently asked questions

 

Physician/

Nurse Practitioner/

Dietitian

Pharmacist CME

(Multidisciplinary Healthcare Provider Presentation)

 

Sponsor: Novo Nordisk Canada Description: Upon completion of this continuing professional development program, participants will be better able to:

 

•       Understand the two classes of incretin agents and their mode of action

•        Differentiate between GLP-1 receptor agonists and DPP-4 inhibitors

•       Review the efficacy and safety data of currently available incretin agents and where they fit in the 2013 CDA guidelines

•       Explain how to optimally incorporate incretin therapies into clinical practice and to discuss the rationale for a personalized evidence-based approach to care

 

 

 

 

Oct 5, 2013 Moncton, New Brunswick Canadian Diabetes Association 2013 Clinical Practice Guidelines Update

 

Pharmacist CME

 

Sponsor: Canadian Cardiovascular Pharmacists Network Description: As a result of attending this educational session the following objectives will be met:

•       Familiar with most major changes within the 2013 CDA clinical practice guidelines

•       Able to apply the recommendations in clinical practice and be familiar with online resources.

 

 

 

 

June 3, 2013 Charlottetown, Prince Edward Island  

Diabetic Peripheral Neuropathy: The Diabetic Foot A Pharmacists Role

 

National Annual Convention Sponsor: Canadian Pharmacists Association As lead author provided a case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion

 

Description Upon completion of this continuing professional development program, participants will be better able to:

•       List the signs, symptoms, and risk factors for developing DPN

•       Screen for DPN as part of routine management of diabetes and its co-morbidities

•       Apply tools to counsel the patient on evidence-based treatment options for painful DPN, and follow up with appropriate interventions

•       Discuss the basic concepts of good foot care to prevent and screen for diabetes foot complications

 

 

June 1, 2013 Charlottetown, Prince Edward Island Advancing Pharmacy Practice in Diabetes
National Annual Convention Sponsor: Canadian Pharmacists Association I was responsible for developing and delivering this one-day interactive workshop providing useful learning and sharing that can be put into practice right away. Topics included lab tests that help assess patient status and individualize therapy; when patients should self-monitor and using pattern management to optimize treatment; promoting lifestyle and nutrition; current evidence on oral agents; managing insulin starts, FIT recommendations for injection technique; the importance of hypoglycemia and lowering the risk from initial screening to long-term complications. Participants will have access to practice and screening tools to use in their pharmacy practice. This workshop is a component of the Diabetes Strategy for Pharmacists and was developed with funding from the Public Health Agency of Canada under the Canadian Diabetes Strategy.

 

 

May 28, 2013 Halifax, Nova Scotia FEEL IT, TRY IT, SWITCH IT – Exploring Lipohypertrophy & Benefits of Proper Injection Technique
Pharmacist CME

 

Sponsor: BD Healthcare, Bayer Healthcare, Lilly Canada Description: As a result of attending this educational (1.5 CE’s) evening the following objectives will be met:

•       Understand what lipohypertrophy is, how it develops and how to prevent it

•       Learn how you can assess and identify lipohypertrophy (lipos)

•       Review practical tips for treatment of lipohypertrophy

•       Review proper injection technique (IT) for people living with diabetes, including proper site rotation

•        Understand the impact of needle length in relation to lipohypertrophy

 

 

May 25, 2013 Fredericton, New Brunswick  

Innovations in Anaphylaxis: Diagnosis, Treatment, and Management of Anaphylaxis

 

Annual Provincial Pharmacists Convention Sponsor: Sanofi Canada Description:  PowerPoint presentation, Lecture, Q&A over 60 minutes. After participating in the following educational program participants should be able to:

    1. Describe the causes, signs, and symptoms of anaphylaxis.
    2. Identify gaps in the diagnosis and management of anaphylaxis.
    3. Understand the diagnostic tests for food allergy.
    4. Identify the appropriate treatment of acute anaphylaxis and long-term management for patients at risk.

The treatment options are provided with “hands-on” practice including the newer devices and comparisons between each are provided discussing both potential advantages of each device style as well as potential concerns as discussed during presentation.

 

May 25, 2013 Fredericton, New Brunswick  

Monitoring with Purpose: Blood Glucose Pattern Management

 

Annual Provincial Pharmacists Convention Sponsor: Sanofi Canada Description: PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy.

 

May 22, 2013 Sydney, Nova Scotia  

Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes

 

Multidisciplinary

Healthcare Professional CME

Sponsor: Novo Nordisk PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes

 

May 22,2013 Antigonish, Nova Scotia  

Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes

 

Pharmacist CE Sponsor: Novo Nordisk PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes

 

May 15, 2013 Moncton, New Brunswick  

Challenging the Hypoglycemia Care Gap 

 

Type Sponsor: Novo Nordisk Description: This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.

 

The objectives of Challenging the Hypoglycemia Care Gap are:

  • Examine the prevalence of hypoglycemia in type 2 diabetes patients on insulin
  • Describe adverse outcomes associated with hypoglycemia
  • Assess for hypoglycemia using simple practice tools
  • Identify several strategies to minimize and manage hypoglycemia in type 2 patients using insulin

 

 

May 14,2013 Moncton, New Brunswick  

Challenging the Hypoglycemia Care Gap 

 

CME , Family MD Sponsor: Novo Nordisk Description This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.

 

The objectives of Challenging the Hypoglycemia Care Gap are:

  • Examine the prevalence of hypoglycemia in type 2 diabetes patients on insulin
  • Describe adverse outcomes associated with hypoglycemia
  • Assess for hypoglycemia using simple practice tools
  • Identify several strategies to minimize and manage hypoglycemia in type 2 patients using insulin

 

 

April 26,2013 Toronto, Ontario  

“Feel IT, Try IT, Switch IT”

 

National Banner Diabetes Convention Sponsor: BD HealthCare This 60-minute national presentation will visit how lipohypertrophy (lipos) can adversely affect glycemic control and how proper injection technique can prevent Lipohypertrophies from developing and also by revisiting and adapting better injection techniques Lipohypertrophies can resolve resulting in better and more consistent glycemic control.

This presentation will present these 3 main topics:

Feel IT

  • Understand what lipohypertrophy is, how it develops and how to prevent it.
  • Learn how you can assess and identify lipohypertrophy (lipos) in your practice.
  • Review practical tips for treatment of lipohypertrophy.

Try IT

  • Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

Switch IT

  • Understand the impact of needle length in relation to lipohypertrophy.

The concepts will be presented using a typical insulin case presentation in a patient who has been using insulin for about 10 years. The patient has had increasing doses of insulin over the years but also has more variability of glycemic control. By investigating the impact of lipohypertrophy and then applying the FIT (Forum for Injection Technique) recommendations, the program will illustrate how as pharmacists we may help overcome the challenges of “lipo’s” by identifying poor injection technique as part of a therapy review.  The role of proper needle length in avoiding intramuscular injections and its potential for causing inconsistent insulin absorption is also discussed.

 

 

 

April 11,2013 Fredericton, New Brunswick  

Challenging the Hypoglycemia Care Gap 

 

Annual Convention Mixed Health Professionals (RN,NP,PhC, RD,MD,etc) Sponsor: Novo Nordisk Description This accredited continuing medical education program is offered to family physicians that have recognized a need for better screening and management of hypoglycemia in diabetic patients who are on insulin. By participating in this case based continuing medical education program you will build your skills related to events and symptoms, as well as the screening and management of hypoglycemia.

 

The objectives of Challenging the Hypoglycemia Care Gap are:

  • Examine the prevalence of hypoglycemia in type 2 diabetes patients on insulin
  • Describe adverse outcomes associated with hypoglycemia
  • Assess for hypoglycemia using simple practice tools
  • Identify several strategies to minimize and manage hypoglycemia in type 2 patients using insulin

 

 

 

 

 

April 4,2013 Vancouver, British Columbia “Feel IT, Try IT, Switch IT”

 

National Banner Diabetes Convention Sponsor::BD HealthCare This 60-minute national presentation will visit how lipohypertrophy (lipos) can adversely affect glycemic control and how proper injection technique can prevent lipohypertrophies from developing and also by revisiting and adapting better injection techniques lipohypertrophies can resolve resulting in better and more consistent glycemic control.

This presentation will present these 3 main topics:

Feel IT

  • Understand what lipohypertrophy is, how it develops and how to prevent it.
  • Learn how you can assess and identify lipohypertrophy (lipos) in your practice.
  • Review practical tips for treatment of lipohypertrophy.

Try IT

  • Review proper injection technique (IT) for people living with diabetes, including proper site rotation.

Switch IT

  • Understand the impact of needle length in relation to lipohypertrophy.

The concepts will be presented using a typical insulin case presentation in a patient who has been using insulin for about 10 years. The patient has had increasing doses of insulin over the years but also has more variability of glycemic control. By investigating the impact of lipohypertrophy and then applying the FIT (Forum for Injection Technique) recommendations, the program will illustrate how as pharmacists we may help overcome the challenges of “lipo’s” by identifying poor injection technique as part of a therapy review.  The role of proper needle length in avoiding intramuscular injections and its potential for causing inconsistent insulin absorption is also discussed.

 

 

 

March 26,2013 Halifax, Nova Scotia  

Incretins: Addressing the Multifactorial Nature of Type 2 Diabetes

 

Local Pharmacy CME/CHE Sponsor: Novo Nordisk PowerPoint and case based interactive program This 60-minute presentation will visit the newer class of agents: The Incretin based therapies. The talk will explore the difference between the 2 classes of medications within this newer class of therapies; the DPP-IV inhibitors and the GLP-1 Agonists. Considerations of incretin effects on other risk factors will be discussed. Also on the presentation agenda is the discussion of ways to support patients in overcoming the injection barrier to achieve effective management of type 2 diabetes

 

March 21,2013 Saint John,

New Brunswick

 

Diabetes in Pharmacy Practice

 

Local Professional CME Sponsor: Bayer Diabetes PowerPoint and case based interactive program, this 60-minute presentation will visit the Canadian Diabetes Association Clinical Practice Guidelines especially as they pertain to Medication management.  The speaker will bring his expertise as part of the expert or writing committee of the Guidelines to the presentation, by providing some of the new and updated recommendations that are pending from the new Diabetes Guidelines to be released next month.

In addition discussions involving the new emphasis on individualizing therapy, goals, and treatments, by visiting the various criteria in determining these objectives will be presented.

 

March 12, 2013 Fredericton Junction, New Brunswick, Canada  

Managing Your Diabetes: The Journey from Metformin to Insulin

 

Local CME/Public Presentation Sponsor: Sanofi Canada Presentation will review the current state of Diabetes in Canada. Included is the role of the Clinical practice Guidelines from the CDA, the role of Monitoring Blood Glucose, the use of medication management and individualization of therapy goals. The early role of injection therapy is explored including the role of Basal insulin and advancing therapy with initiating mealtime insulin.

 

Nov 27, 2012 Rothesay,

New Brunswick, Canada

 

Simple Steps: Starting and Intensifying Insulin in Type 2 Patients

 

Local CME Sponsor: Novo Nordisk PowerPoint and case based interactive program in identifying patients needing insulin therapy and also when to intensify insulin therapy
Nov 22, 2012 Moncton,

New Brunswick, Canada

 

Simple Steps: Starting and Intensifying Insulin in Type 2 patients

 

Local Pharmacy CHE/CME Sponsor: Novo Nordisk PowerPoint and case based interactive program in identifying patients needing insulin therapy and also when to intensify insulin therapy
Oct 12, 2012 Vancouver,

British Columbia, Canada

 

Diabetes Painful NEUROPATHY: A Pharmacy Case

 

National Convention Sponsor: Pfizer A case based presentation providing participants kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communications forms to relay information on other healthcare professionals. PowerPoint, Q&A, Interactive Case Discussion

 

Oct 5, 2012 St. John’s, Newfoundland, Canada  

Simple Steps: Starting and Intensifying Insulin in Type 2 patients

 

Local Pharmacy CHE/CME Sponsor: Novo Nordisk PowerPoint and care based interactive program in identifying patients needing insulin therapy and also when to intensify Insulin Therapy

 

Oct 4, 2012 St. John’s, Newfoundland, Canada  

Simple Steps: Starting and Intensifying Insulin in Type 2 patients

 

Local Pharmacy CHE/CME Sponsor: Novo Nordisk PowerPoint and care based interactive program in identifying patients needing insulin therapy and also when to intensify Insulin Therapy

 

Oct 3, 2012 Moncton,

New Brunswick, Canada

 

Helping You to Help Your Patients With Type 2 Diabetes

 

Atlantic Aboriginal Nurses Annual Meetings Sponsor: Merck Canada PowerPoint presentation, lecture, Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered.

 

Sept 23, 2012 Fredericton,

New Brunswick, Canada

 

Monitoring with Purpose: Blood Glucose Pattern Management

 

Local Pharmacists CHE/CME Sponsor: Sanofi Canada PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy.
July 25, 2012 Sussex, New Brunswick, Canada  

Monitoring with Purpose: Blood Glucose Pattern Management

 

Train the Trainer Sponsor: Sanofi Canada PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. Provided training as a Master Trainer of the program.

 

June 2, 2012 Whistler,

British Columbia, Canada

 

Are Your Patients Fit? Release of the Canadian Injection Recommendations

 

CPhA Annual General Meeting and Convention Sponsor: Canadian Pharmacists Association CPhA As a member of the Founding FIT Board delivered the document to the attendees and highlighted the overarching view of the printed recommendations. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and  needs of special populations.

 

May 31-June 1, 2012 Whistler,

British Columbia, Canada

 

Diabetes Strategy for Pharmacists

 

CPhA Annual General Meeting and Convention Sponsor: Canadian Pharmacists Association CPhA A 2 day 8 module overview on Diabetes and its therapies. Combination of PowerPoint, case study, hand-on workshop, and didactic learning

 

May 26, 2012 Saint John,

New Brunswick, Canada

 

Are Your Patients Fit? Release of the Canadian Injection Recommendations

 

NB Pharmaceutical Society and Pharmacy Association Annual Convention Sponsor: BD Healthcare As a member of the Founding FIT Board delivered the document to the attendees and highlighted the overarching view of the printed recommendations. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations.

 

May 25, 2012 Saint John,

New Brunswick, Canada

 

Diabetes Painful Neuropathy: A Pharmacy Case

 

NB Pharmaceutical Society and Pharmacy Association Annual Convention Sponsor: Pfizer Canada A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and interactive case discussion depending on size of group

 

May 24, 2012 Saint John,

New Brunswick, Canada

 

Monitoring with Purpose: Blood Glucose Pattern Management

 

Local CHE/CME Event Sponsor: Sanofi Canada PowerPoint Presentation, lecture, Q&A. Included is 5 potential patient cases for discussion. The presentation demonstrates utilizing a new tool that organizes blood glucose values to identify patterns and how to analyze and respond to these patterns. The cases include identifying when to add a second/third agent, hypoglycaemia, starting basal insulin, and using or needing to adjust diet therapy.

 

May 23, 2012 Rexton, New Brunswick, Canada  

Integrating Incretins into Everyday Management of Diabetes

 

Luncheon CME-Physicians Sponsor: Novo Nordisk A PowerPoint, Q&A, and case based study on the role of Incretins in managing Type 2 Diabetes

 

May 6, 2012 Calgary. Alberta, Canada  

Diabetes Painful Neuropathy: A Pharmacy Case

 

Wal-Mart Western Pharmacists Annual Meetings Sponsor: Pfizer Canada A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and Interactive Care Discussion depending on the size of the group

 

April 17, 2012 Fredericton,

New Brunswick, Canada

 

Are Your Patients Fit? Release of the Canadian Injection Recommendations

 

NB Diabetes Educator Sector Annual Meeting Sponsor: BD Diabetes As a member of the Founding FIT Board was part of the group that delivered the document to the attendees and highlighted the overarching view of the printed recommendations

 

April 15, 2012 Toronto, Ontario, Canada  

Diabetes Painful Neuropathy: A Pharmacy Case

 

Wal-Mart Eastern Pharmacists Annual Meetings Sponsor: Pfizer Canada A case based presentation providing participant kits with tools for screening checklist for patient discussion, DPN-4 Screening tool and communication forms to relay information on other healthcare professionals. PowerPoint, Q&A, and Interactive Care Discussion depending on the size of the group

 

April 13, 2012 Moncton,

New Brunswick, Canada

 

Pattern Management

 

Local Nurse Practitioner CHE/CME Sponsor: LifeScan Canada PowerPoint, Q&A, Case based presentation on the use of blood glucose management to identify patterns and solutions for patients needing better glycemic control.

 

March 28, 2012 Toronto, Ontario, Canada  

Star System Launch

 

National Launch Sponsor: Sanofi Canada National launch of StarSystem website, provided interviews with pharmacy based media (Pharmacy practice etc.…), was present as part of the entourage of health professionals that developed and had written the material for the site

 

March 22, 2012 Fredericton,

New Brunswick, Canada

 

Anaphylaxis and its Treatment: New Program Developed

 

Corporate Presentation Sponsor: Pfizer Canada PowerPoint and Lecture Q&A & Hands on Demo. Delivered to Maritime Pharmacy Managers in Preparation for new program on developing Adherence/Follow-up/Compliance Program on Epi-Pens etc…

 

 

 

March 21, 2012 Saint John,

New Brunswick, Canada

 

Treat to Target: Insulin Therapies

 

Local CHE/CME Update Sponsor: Sanofi Canada PowerPoint and Lecture Q&A, Delivered to Extra Mural Nurses and via Satellite to 2 other sites. The main topic is how to progress a patient onto injection therapy including insulin therapy. Initializing basal insulin and advancing therapy onto mealtime insulin utilizing case presentations and practice tools are utilized.

 

Feb 28, 2012 Mont Tremblant, Quebec, Canada  

Star System Launch

 

Corporate Launch Sponsor: Sanofi Canada Was an expert advisor/presenter on material involved in developing the website accompanying the newly launched monitor. Case/real situational presentation along with Q&A as asked by the attendees

 

Feb 2, 2012 Charlottetown,

Prince Edward Island, Canada

 

Forum for Injection Techniques (FIT)/ Overview of Incretins

 

Local Nurse /Nurse NP CHE/CME Sponsor: NovoNordisk PowerPoint and Lecture Q&A given to Prince Edward Island group of Diabetes Nurse Practitioners

 

Jan 25, 2012 Saint John,

New Brunswick, Canada

 

Forum for Injection Techniques (FIT)/ Overview of Insulin 201

 

Local Nurse /Nurse NP CHE/CME Sponsor: Sanofi Canada PowerPoint and Lecture Q&A for Southern New Brunswick Nurse Practitioner and Pharmacists group

 

Dec 14, 2011 Saint John,

New Brunswick, Canada

 

The Pharmacist’s Role in the Management of Type 2 Diabetes:

Integrating GLP-1 Therapy in Diabetes Patient Care Management

 

Local Pharmacy CME/CHE Sponsor: NovoNordisk The topic of the newer class of Incretins, the Glucagon Like Peptide-1 (GLP-1), is explored and integrating them into the algorithm of today’s therapy was discussed. The advantages and compatibilities of this new class were discussed. PPT, Q & A, and case presentations are used to deliver the program.

 

Oct 28, 2011 Toronto, Ontario, Canada  

Are Your Patients FIT?  Release of the Canadian Injection Recommendations

 

CDA/CSEM Professional Conference & Annual General Meeting Sponsor: BD Diabetes As a member of the founding FIT Board was part of the group that delivered the document to the attendees and highlighted the overarching view of the printed recommendations. This was the official release of the document in Canada. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations.

 

Aug 29, 2011 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with Epi-Pen & Twinject

 

Local School Lecture & Demonstration Sponsor: School District 6 Lecture and demonstration reviewing anaphylaxis signs, symptoms, causes, prevention, and hands on demonstration on how Epi-Pens are to be used. Given to Staff, Teacher Aides
May 26-27, 2011 Montreal, Quebec, Canada  

Diabetes Strategy for Pharmacists

 

Pre Conference Workshop Sponsor: Canadian Pharmacists Association CPhA A 2 day 8 module overview on Diabetes and its therapies. Combination of PowerPoint, case study, hands-on workshop, and didactic learning

 

May 10, 2011 Moncton,

New Brunswick, Canada

 

Introduction to Incretins Insulin, and Injection Devices

 

Atlantic Aboriginal Diabetes Initiative Sponsor: Health Canada PowerPoint, Q&A, a 60 minute presentation introducing new issues on diabetes management including the new class “Incretins” and where their place in therapy will be, Glargine was approved for this population so introduction to Insulin and Insulin delivery was also presented

 

May 10, 2011 Moncton,

New Brunswick, Canada

 

FIT Canada (Forum for Injection Technique)

 

Atlantic Aboriginal Diabetes Initiative Sponsor: Health Canada PowerPoint, Case Study, and Q&A, a 90-minute presentation on the results of the TITAN meeting and proper injection techniques. The included topics range from preparing to inject, correct use of devices, disposal of injection material, factors involving absorption from different sites, injection site health, rotation of sites, bruising and bleeding, lipohypertrophy avoidance, physical aspects of the injection material, and needs of special populations.

 

April 2, 2011 Fredericton,

New Brunswick, Canada

 

Helping You to Help Your Patients With Type 2 Diabetes

 

NB Diabetes Educator Sector Annual Meeting Sponsor: Merck Canada PowerPoint presentation, lecture and Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered.

 

March 24, 2011 Halifax, Nova Scotia, Canada  

Influencing Best Practice in Injection Technique

 

Local CME/CHE Pharmacists/

Nurse CDE NP

Sponsor: BD Healthcare Present information of the TITAN survey and the new recommendation for injection techniques to fellow health professionals. Emphasis was placed on the main messages of avoiding IM injections by assuring proper placement of insulin injections (re: needle length, proper injection technique, rotation etc. Avoiding complications) Presented minor case that was seen by presenter that recently emphasized the role of revisiting the basics that should be done periodically to optimize insulin therapy

 

Feb 22, 2011 Saint John,

New Brunswick, Canada

 

Incretins: GLP-1 vs. DPP-IV, Focus on Liraglutide

 

Local CME/CHE Sponsor: Novo Nordisk PowerPoint presentation on the Incretin therapies covering the role that each have (GLP-1 and DPP-4) the differences between the 2 classes and focusing on the newest agent Liraglutide (a GLP analogue) and its pharmacology, expected results, where it may fall in therapy with 2 case studies included. Attended by multi disciplinary healthcare workers and teleconferenced to other remote sites with concurrent slide presentation

 

 

Oct 20, 2010 Edmonton, Alberta, Canada  

The View on Diabetes

 

CDA/CSEM Professional Conference and Annual Meetings Sponsor: Sanofi Diabetes Presented as part of multi-disciplinary healthcare team as a parody of the television show “The View”. A person with diabetes who also was a comedian; Joey Elias was moderator and all participants contributed to major topics involving issues around diabetes care from A1c, pattern management, nutrition compliance, psychological issues around diabetes, and medical management of diabetes

 

June 29, 2010 Quispamsis,

New Brunswick, Canada

 

Update on Insulin & Insulin Delivery Devices

 

Local CME Sponsor: Novo Nordisk Original PowerPoint presentation, lecture, and Q&A covering newer insulin and injection therapies including newer delivery devices and adjusting methodology

 

May 28, 2010 Saint John,

New Brunswick, Canada

 

Helping You to Help Your Patients With Type 2 Diabetes

 

NB Pharmacists Association Annual Conference & Trade Show Sponsor: Merck Canada PowerPoint presentation, lecture and Q&A, 90 minute lecture. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered.

 

May 16-18, 2010 Calgary, Alberta, Canada  

Insulin Pump Therapy: Just the Basics

 

CPA Annual National Conference & Trade Show Sponsor: Canadian Pharmacists Association CPhA An original program developed to provide as described the basics of pump therapy from theory of pump therapy, language of pump therapy, who is a good candidate, advantages of pump therapy, supplies and how the system is put together, costs, insurances, and how we determine initial doses for basal and bolus rates, other areas discussed. Provided two “Hands-on” sessions, 90 minutes each

 

May 14-15,2010 Calgary, Alberta, Canada  

Diabetes Workshop: The How to of Managing Diabetes…

A Prescription of Pharmacists

 

CPA Annual National Conference & Trade Show Sponsor: Canadian Pharmacists Association CPhA As Canadian Diabetes Champion for Pharmacists: co-delivered a 2-day, 9-hour workshop on the role of Pharmacists in Diabetes care. Session was a combination of PowerPoint, Hands-on, workshop, interaction

 

April 29-30, 2010 Saint John’s Newfoundland, Canada  

Helping You to Help Your Patients With Type 2 Diabetes

 

Provincial DES Conference Sponsor: Merck Canada 90 minute PowerPoint presentation, lecture and Q&A provided as a keynote presentation to the provincial DES annual meeting. Audience was mostly Hospital & Clinical Diabetes Educators including registered Nurses, Dieticians, Pharmacists and other allied Health Care Workers

 

 

 

 

April 14, 2010 Rothesay,

New Brunswick, Canada

 

Circadian Rhythm of Blood Pressure: Implications for Clinical Practice

 

Local CHE/CME Sponsor: BioVail PowerPoint Presentation, discussion, and Q&A on chronotherapy and novel drug delivery systems and how they may improve control by utilizing new technology.

 

March 26, 2010 Fredericton,

New Brunswick, Canada

 

Helping You to Help Your Patients With Type-2 Diabetes

 

NB Diabetes Educator Sector Annual Meeting Sponsor: Merck Canada Acted as facilitator for opening session and provided abbreviated version of above program on day 2 of convention

 

Feb 25, 2010 Saint John,

New Brunswick, Canada

 

A Review of Medications & an Update on New Devices

 

Local CME

Multidisciplinary

Health Professions

Sponsor: Lilly Canada PowerPoint Presentation, discussion and Q&A on what is new in medications for diabetes (Incretins, etc.) as well as what is new for devices including Contour USB meter and other new devices

 

Feb 21, 2010 Sudbury, Ontario, Canada  

Diabetes Workshop: The How to of Managing Diabetes…

A Prescription of Pharmacists

 

Pharmacy based CME/CHE Sponsor: Canadian Pharmacists Association CPhA As Canadian Diabetes Champion for Pharmacists: co-delivered a 2-day, 9-hour workshop on the role of Pharmacists in Diabetes care. Session was a combination of PowerPoint, Hands-on, workshop, interaction

 

Jan 31, 2010 Toronto, Ontario, Canada  

Helping You to Help Your Patients With Type 2 Diabetes

 

Canadian Society of Hospital Pharmacists: Professional Conference Sponsor: IntraMed Group/Merck Canada Satellite session to Professional Practice Conference 90 minute lecture PowerPoint, Q&A to audience of Hospital and Clinical Pharmacists. This was the official launch of the program. This presentation covers a general review of diabetes including statistics; types of diabetes, therapeutic goals, medication management, comorbidities, and specific topics of legacy effect and incretin effect will be covered.

 

Jan 12, 2010 Quebec City, Quebec, Canada  

The 5 Minute Manager

 

Abbott Diabetes Care Team AGM Sponsor: Abbott Diabetes Care Presentation of a new program including “Start Right, Right Away”. Included tools, Discussion Q&A, and PowerPoint presentation. Presented to mainly Diabetes Sales Force and Executives of Abbott Diabetes Care

 

Nov 18, 2009 Saint John,

New Brunswick, Canada

 

Diabetes Care Update and Insulin Pump Introduction

 

Long Term Care Workers Sponsor: Lawtons Drugs PowerPoint, Lecture, Q&A Session, personally hooked up to an insulin pump to demonstrate the various parts, its functionality, use, and review the pump supplies (i.e. reservoirs, infusion sets, insertion devices, etc.)  A general review of diabetes medication management also was provided to position where insulin is used and then identifying who may be a good candidate to use the insulin pump.
May 31, 2008 Miramichi,

New Brunswick, Canada

 

Medication: It’s Not Always About Your Blood Sugars

 

Canadian Diabetes Expo Sponsor: Canadian Diabetes Association PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered Dieticians, Industry Reps, People with Diabetes, Canadian Diabetes Association Representatives about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices.

 

April 17, 2008 Moncton,

New Brunswick, Canada

 

Update on Diabetes Medications & Treatments

 

CHE, CME Evening Session Sponsor: Sanofi Canada PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered dieticians, pharmacists, industry reps about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Emphasis placed on the role of insulin and long acting analogue insulin and its impact on therapy was provided.

 

April 4, 2008 Fredericton,

New Brunswick, Canada

 

Medications: Trials & Tribulations

 

Provincial Convention Sponsor: Diabetes Educator Sector PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered dieticians, EMH staff, Nurse practitioners, and physicians about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Also included were the various medications used to manage the co-morbidities associated with diabetes (CVD- cholesterol, blood pressure, kidney protection)

 

Nov 28, 2007 Saint John,

New Brunswick, Canada

 

Long Acting Insulin Analogues: Focus on Glargine

 

Extra Mural Nurses Sponsor: Sanofi Canada PowerPoint, Lecture, Q&A Discussion provided to RN Nurse educators, Registered Dieticians, EMH staff on insulin Glargine. Its advantages over insulin NPH, how to switch from NPH insulin, dosages, and reviewed the devices used to deliver Glargine.

 

Nov 20, 2007 Saint John,

New Brunswick, Canada

 

Signature Speaker Series: Diabetes: What You Need to Know

 

Public Presentation Sponsor: Canadian Diabetes Association PowerPoint, Lecture, Q&A provided to the T.O.P.S. on the basics of what diabetes is, its prevalence, its symptoms and it management.

 

Nov 9, 2007 Moncton,

New Brunswick, Canada

 

Targeting Patient Needs when Treating & Managing Diabetes

 

Multi Disciplinary

CHE/CME

Sponsor: GSK Prisme-Diabetes Program PowerPoint, Lecture, Q&A Discussion provided about the role of the different medications used to treat diabetes, how they can be used together, and how to progress therapy based on current best practices. Emphasis placed on the role of insulin and long acting analogue insulin and its impact on therapy was provided. Program included “breakout sessions” for more targeted presentations to specific health professional groups

 

 

 

Oct 27, 2007 Vancouver,

British Columbia, Canada

 

Establishing a Pharmacist/CDE Practice within a Retail Pharmacy Setting

 

CDA/CSEM Professional Conference and Meetings Sponsor: Canadian Diabetes Association PowerPoint, Lecture, Q&A Discussion provided during the Pharmacy Symposium on the evolving role of the pharmacist in the collaborative care of the person with diabetes. Areas emphasized included general medication management and the role of the pharmacist in initializing insulin therapy and the role in adjusting insulin therapy

 

Oct 11, 2007 Charlottetown,

Prince Edward Island, Canada

 

Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!

 

Pharmacy based CME Sponsor: Roche Diagnostics PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes

 

Oct 10, 2007 Saint John,

New Brunswick, Canada

 

Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!

 

 

Pharmacy based CME Sponsor: Roche Diagnostics PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes

 

Oct 4, 2007 Moncton,

New Brunswick, Canada

 

Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!

 

 

Pharmacy based CME Sponsor: Roche Diagnostics PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy TechniciansPowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes

 

 

Oct 3, 2007 Fredericton,

New Brunswick, Canada

 

Diabetes Education: Where Dies Pharmacy Fit? How We Can Make a Difference!

 

Pharmacy based CME Sponsor: Roche Diagnostics PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy TechniciansPowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on the role of the pharmacist and pharmacy technician in helping people with diabetes manage their diabetes. Diabetes prevalence, complications from uncontrolled diabetes, monitoring parameters, general lifestyle management, and identifying who may be part of the patient’s treatment team. The presentation then progressed on to the role of the pharmacy at different service levels, including the role of the technician in helping choose the right monitor. The types of services provided by the different provinces were presented. The session wrapped up by discussing new and innovative therapies such as insulin pumps, new medications, and new programs available to help people with diabetes

 

June 27, 2007 Moncton,

New Brunswick, Canada

 

The Art of Diabetes Education & Care

 

Multidisciplinary

CME/CHE

Sponsor: Eli-Lilly Canada Moderated and Facilitated Presentation by Kris Swenson of the Diabetes University, Phoenix, Arizona. Acted as co-presenter in a generalized talk “The Art of Diabetes Education and Care”.

 

June 21, 2007 Rothesay,

New Brunswick, Canada

 

S.M.A.R.T. Therapy: A New Paradigm in Asthma Therapy

 

Pharmacy CME Sponsor: AstraZeneca Introduced new concept in approaching Asthma therapy and where it may fit in Treatment Continuums

 

June 9-10, 2007 Brudnell Resort,

Prince Edward Island, Canada

 

Advances in Pharmaceutical Science & New Horizons in Pharmacotherapy

 

Family Medicine

CHE

Sponsor: BioVail Provided six 1-hour sessions on above topic to Family Practitioners and Specialists. Topic involved in new delivery systems and how it may benefit medication management by improving the method of drug delivery

 

June 1, 2007 Saint John,

New Brunswick, Canada

 

Ask the Expert

 

New Brunswick Dental Association Annual General Meeting Sponsor: Canadian Diabetes Association Available to convention attendees to answer questions involving Diabetes and issues surrounding the “Metabolic Syndrome”. Provided screening for blood glucose results as well as total cholesterol readings and information on different treatment modalities.

 

May 9, 2007 Saint John,

New Brunswick, Canada

 

Optimizing Diabetes Care

 

Pharmacists/ Pharmacy  CME/CHE Sponsor: Bayer Healthcare PowerPoint, Lecture, Q&A Discussion provided to Pharmacists/ Pharmacy Technicians. Topics included the CDA CPG Guidelines and its goals for therapies. The role of the technician and helping choose the proper monitor. The use of monitoring in the role of adjusting medications was discussed. The role of the collaborative team in managing diabetes and how these roles can be identified and enhanced by better interaction was delivered.

 

May 7, 2007 Saint John,

New Brunswick

 

Ask the Expert

 

Health Fair/Public Presentation Sponsor: Pfizer Canada Available to attendees to answer questions involving Diabetes and issues surrounding the “Metabolic Syndrome”. Part of expert panel with Dietician and nurse CDE. Components of the metabolic syndrome were discussed as well as screening was provided to willing participants to emphasize which target values we are screening for.

 

Dec 6, 2006 Saint John,

New Brunswick, Canada

 

Self Monitoring of Blood Glucose

You Don’t Have to be UltraSmart to use the UltraSmart Meter

 

Pharmacists/ Pharmacy Technicians Sponsor: LifeScan Canada PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values

 

Nov 20, 2006 Moncton,

New Brunswick, Canada

 

Self Monitoring of Blood Glucose

You Don’t Have to be UltraSmart to use the UltraSmart Meter

 

Pharmacists/ Pharmacy Technicians Sponsor: LifeScan Canada PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values

 

Nov 14, 2006 Fredericton,

New Brunswick, Canada

 

Self Monitoring of Blood Glucose

You Don’t Have to be UltraSmart to use the UltraSmart Meter

 

Pharmacists/ Pharmacy Technicians Sponsor: LifeScan Canada PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values

 

Nov 2, 2006 Saint John,

New Brunswick, Canada

 

Self Monitoring of Blood Glucose

You Don’t Have to be UltraSmart to use the UltraSmart Meter

 

Pharmacists/ Pharmacy Technicians Sponsor: LifeScan Canada PowerPoint, Lecture, Q&A Discussion provided to Pharmacists and Pharmacy Technicians on A1c levels. Influence of testing on maintaining good levels and the relationship of food, insulin, and timing on blood glucose values

 

Nov 2, 2006 Saint John,

New Brunswick, Canada

 

Chronotherapy, Glumetza and it’s Role in Treatment of Diabetes

 

Multidisciplinary CME/CHE Sponsor: BioVail Pharmaceuticals PowerPoint, Lecture provided to Diabetic Educators. Involved with patient care within the Clinical setting. Emphasis on new delivery technology and how it can positively impact patient outcomes and reduce side effects was discussed. The role of timed delivery to maximize medication effect was also explored.

 

 

 

 

 

 

Oct 11, 2006 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen and Twinject

 

School Staff Presentation Sponsor: Kennebecasis Drugs Ltd. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Oct 5, 2006 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen and Twinject

 

School Staff Presentation Sponsor: Kennebecasis Drugs Ltd. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Sept 28, 2006 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen and TwinJect Device

 

School Staff Presentation Sponsor: Kennebecasis Drugs Ltd. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Sept 27, 2006 Truro, Nova Scotia, Canada  

Insulin Pump Therapy 101: Just the Basics

 

Multidisciplinary CME/CHE Sponsor: Sanofi Canada PowerPoint, Lecture provided to Educators, Physicians and Dietician of Cumberland County. Reviewed role of insulin and provided background information on Insulin Pumps and their therapies. Discussed advanced features, demonstrated real time Glucose Monitoring by wearing a monitor. Discussed what is in the future for monitoring and the future of Insulin Pumps

 

Sept 25, 2006 Saint John,

New Brunswick, Canada

 

Long Acting Analogues: One Year Later

 

Diabetes Educator Sector Meeting Sponsor: Sanofi PowerPoint presentation given to Certified Diabetic Educators, Pharmacists, Dieticians etc. Review of insulin therapies, role of long acting insulin, advantages of the new long acting analogues, have they lived up to the hype?

 

Aug 23, 2006 Moncton,

New Brunswick, Canada

 

Creating Diabetes Magic

 

Multidisciplinary CME/CHE Sponsor: Eli Lilly Canada Acted as moderator/host for the program given by Kris Swenson (RN CDE Diabetes Management & Training Centers Inc.)

 

June 12, 2006 Saint John,

New Brunswick, Canada

 

What You Need to Know About Diabetes

 

Administrative Executive Program (NBCC) Sponsor: Canadian Diabetes Association PowerPoint, Lecture covering Diabetes in the workplace and what can be done for prevention and screening to identify people at risk. Symptoms and signs of diabetes were reviewed, along with prevalence and various general topics around diabetes were presented for discussion
June 8, 2006 Saint John,

New Brunswick, Canada

 

Simplified: Starting Insulin & Managing Patients

 

Type Sponsor: NovoNordisk PowerPoint presentation establishing the case for insulin therapy, discussed the initiation of insulin therapies, including new long acting analogues and concerns of initiating insulin. Comparisons of the delivery devices were also provided.

 

May 13, 2006 Fredericton,

New Brunswick, Canada

 

From Pills to the Gila Monster: How We Treat Your Diabetes

 

CDA Annual Meeting (New Brunswick Branch) Sponsor: Canadian Diabetes Association Presentation given to the annual meeting of the Canadian Diabetes Association (CDA) New Brunswick Branch. Lecture reviewing statistics of Diabetes, and treatment from past, present and what is up and coming for the future

 

May 12, 2006 Saint John,

New Brunswick, Canada

 

Medication & Diabetes: Establishing The Foundation

 

Nurse Practitioner Annual Meeting/ CME Sponsor: AstraZeneca Presentation involved the basis of why medications are needed for the treatment of Diabetes, and treatment of comorbidities (ACE therapy, ASA therapy, Statins etc.). The emphasis on interactions and proper dosing was presented.

 

March 22, 2006 Quispamsis,

New Brunswick, Canada

 

Diabetes Survival: Things You Need To Know

 

Public Presentation Sponsor: Canadian Diabetes Association PowerPoint, Handouts, Q&A used to cover “Survival Techniques” as if someone had been newly diagnosed with Diabetes.

 

March 21, 2006 Saint John,

New Brunswick, Canada

 

Diabetes Awareness

 

Public Presentation Sponsor: University of New Brunswick Presentation of “What is diabetes, the prevention of Diabetes, and how to live well with Diabetes”

 

Feb 7, 2006 Saint John,

New Brunswick, Canada

 

Blood Glucose Monitoring: Just the Basics

 

Family Medicine CHE Sponsor: Roche Pharmaceuticals Presentation given about the need to test Blood Glucose and its importance to your patients, roundtable discussion on related topics involving monitoring issues and procedures was provided.

 

Dec 1, 2005 Saint John,

New Brunswick, Canada

 

Continuity of Care: From Diabetes Teaching to Your Counter

 

Pharmacy CME Sponsor: GlaxoSmithKline Presentation involving the methods and programs used at the Diabetes Education Centre (DEC) , reviewed the 2003 Guidelines, discussed the role of the TZD in treatment of Diabetes

 

 

 

 

Nov 29, 2005 Hampton,

New Brunswick, Canada

 

Diabetes Awareness Night

 

Public Presentation Sponsor: Saint John Regional Hospital Presentation given about Diabetes and the seriousness of the disease. The presentation was part of a multidisciplinary panel each providing a session on their specialty- nursing, dieticians, pharmacy

 

Nov 7, 2005 Saint John,

New Brunswick, Canada

 

Update from the Canadian Diabetes Association Annual Meeting, Edmonton Alberta

 

Diabetes Educator Fall Meeting Sponsor: Diabetes Educator Sector In-service to the Diabetes Educator Sector Region 2 Fall meeting on programs attended at the above Annual Meeting.

 

Oct 5, 2005 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen and TwinJect Device

 

School Staff Presentation Sponsor: New Brunswick School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Sept 29, 2005 Quispamsis,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen Device

 

School Staff Presentation Sponsor: New Brunswick School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Sept 28, 2005 Quispamsis,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen Device

 

School Staff Presentation Sponsor: New Brunswick School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Sept 20, 2005 Rothesay,

New Brunswick, Canada

 

Anaphylaxis and its Treatment with EpiPen Device

 

School Staff Presentation Sponsor: New Brunswick School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

March 21, 2005 Rothesay,

New Brunswick, Canada

 

Lantus Insulin & Welcome to Diabetes

 

Multidisciplinary CME/CHE Sponsor: Sanofi Canada Presentation of a new insulin to the group, an expanded version of “Welcome to Diabetes” with more emphasis on listening techniques and interaction with the audience.

 

Nov 25, 2004 Saint John,

New Brunswick, Canada

 

Achieving Diabetes Control with Optimal Blood Glucose Monitoring

 

Pharmacy CME Sponsor: Bayer Healthcare Presentation involving the role of self-monitoring of blood glucose in the management of Diabetes

 

Nov 3, 2004 Fredericton, New Brunswick, Canada  

Welcome to Diabetes

Best Practices Initiatives

 

Multidisciplinary CHE/CME Sponsor: CADTH Presented “Best Practices Initiatives” during meetings of COMPUS (Canadian Optimal Medication Prescribing & Utilization Service) a new program provided by CCOHTA (Canadian Coordinating Office for Heath Technology Assessment)

 

April 22, 2004 Saint John,

New Brunswick, Canada

 

Sense of Urgency in Asthma Treatment

 

Pharmacy CME Sponsor: GlaxoSmithKline Facilitated discussion on Asthma guidelines, Pharmacy intervention, role of Pharmacist, use of tools, dangers of undertreated Asthma

 

Feb 25,2004 Quispamsis,

New Brunswick, Canada

 

Smoking Cessation

 

General Public Presentation Sponsor: Kennebecasis Drugs Ltd. Prepared & Presented presentation and Q&A session to provide information for students looking to quit smoking.

 

Nov 4, 2003 Saint John,

New Brunswick, Canada

 

Arthritis Overview and Treatments

 

General Public Presentation Sponsor: Pfizer Canada Prepared & Presented presentation and Q&A session involving various arthritis treatments and Over-the-counter products used in the treatment of arthritis

 

Nov 13, 2002 Rothesay,

New Brunswick, Canada

 

A Night of Women’s Health Issues

 

General Public Presentations Sponsor: Kennebecasis Drugs Ltd. Acted as facilitator and mater of ceremonies covering a number of topics involving women’s issues and natural treatments to help relieve these issues.

 

 

 

 

 

 

Nov 29, 2002 Hampton,

New Brunswick, Canada

 

OTC’s & Prescription Medications and Their Effect on Alertness

 

School District Employee General Education Sponsor: Kennebecasis Drugs Ltd Prepared and delivered a 60-minute session on the effects of prescription medications and over-the-counter medications may have on alertness and performance. Emphasis was for bus drivers and personal care workers or educational assistants who are directly responsible for childcare.

 

Sept 24, 2002 Rothesay,

New Brunswick, Canada

 

Symptoms & Treatment of Anaphylaxis & EpiPen

 

School Staff Presentation Sponsor: School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Feb 22, 2002 Rothesay,

New Brunswick, Canada

 

Pharmacist Bob’s Traveling Drug Show

 

School student Presentation Sponsor: Rob Roscoe (to become R-2 Consulting) An award winning presentation involving a variety of topics including “good” vs. “bad” drugs using a board with candy vs. drug demonstration, what a pharmacist does, nicotine & alcohol as drugs, etc.

 

Oct 15, 2001 Rothesay, New Brunswick, Canada  

Symptoms & Treatment of Anaphylaxis & EpiPen

 

School staff presentation Sponsor: School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Fall 2000 Saint John,

New Brunswick, Canada

 

Symptoms & Treatment of Anaphylaxis & EpiPen

 

School Staff Presentation/ BUS Drivers Sponsor: School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

Fall 2000 Hampton,

New Brunswick, Canada

 

Symptoms & Treatment of Anaphylaxis & EpiPen

 

School Staff Presentation/ Bus Drivers Sponsor: School District Service provided to teachers, staff and concerned parents. In school service provided to teachers, staff, and concerned parents. Lecture and Demonstration reviewing Anaphylaxis signs, symptoms, causes, prevention and hands on demonstration on how EpiPens and TwinJect are to be used utilizing expired product and discharging the devices to better assess how the injection would sound and feel in a real life scenario.

 

June 13, 2000 Fredericton, New Brunswick, Canada  

Smoking Cessation

 

New Brunswick Pharmacy Conference Sponsor: Glaxo/Wellcome Description

 

Nov 19, 1999 Saint John, New Brunswick, Canada  

Smoking Cessation

 

Type Sponsor: Glaxo/Wellcome Description

 

Oct 1999 Bathurst, New Brunswick, Canada  

Smoking Cessation

 

Type Sponsor: Hoescht Pharmaceuticals Description

 

May 7, 1999 Fredericton, New Brunswick, Canada  

New Smoking Cessation Medications and Nicotine Replacement Therapies: Their Role in Smoking Cessation

 

Type Sponsor: Glaxo/Wellcome Description

 

 

Nov 19, 1998 Moncton, New Brunswick, Canada  

Helping Your Patient Quit Smoking: The Pharmacist as Key Partner

 

Continuing Education Session Sponsor: Glaxo/Wellcome Description

 

Nov 17, 1998 Saint John, New Brunswick, Canada  

Helping Your Patient Quit Smoking: The Pharmacist as Key Partner

 

Continuing Education Session Sponsor: Glaxo/Wellcome Description

 

Fall 1998 Rothesay, New Brunswick, Canada  

Safe Use of EpiPens and Management of Allergic Reactions

 

Type Description

 

Fall 1998 Quispamsis, New Brunswick, Canada  

Safe Use of EpiPens and Management of Allergic Reactions

 

Type Description

 

Spring 1998 Kennebecasis Valley, New Brunswick, Canada  

Safe Use of EpiPens and Management of Allergic Reactions

 

Type Description

 

Oct 16, 1996 Quispamsis, New Brunswick, Canada  

Depression: A Community Perspective

 

Type Sponsor: Eli Lilly & Canadian Mental Health Description

 

Nov 15, 1985 Fredericton, New Brunswick, Canada  

Breast Cancer Treatments

 

Type Sponsor: Merck Canada Description

 

Date Location  

Title

 

Type Sponsor Description

 

 

 

Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description

 

Date Location  

Title

 

Type Sponsor Description